打开搜索

TOFIDENCE™®Tocilizumab（400mg/20mL）

Please take it under the guidance of experienced pharmacist.

TOFIDENCE (tocilizumab-bavi), is a treatment developed as a biosimilar to the reference product ACTEMRA. TOFIDENCE is indicated for the treatment of moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and systemic juvenile idiopathic arthritis in the US and EU.

药品说明书 TOFIDENCE™®

Rheumatoid Arthritis (RA)

Adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs).

Polyarticular Juvenile Idiopathic Arthritis (PJIA)

Patients 2 years of age and older with active polyarticular juvenile idiopathic arthritis.

Systemic Juvenile Idiopathic Arthritis (SJIA)

Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.

微信公众号

尊龙凯时

TOFIDENCE™®Tocilizumab（400mg/20mL）

Please take it under the guidance of experienced pharmacist.